Establishment Inspection Report

Lupin gets Establishment Inspection Report from USFDA for Pithampur facility unit; stock falls 1.88%

Drug firm Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for a unit of its Pithampur facility in Madhya Pradesh.

Lupin gets establishment inspection report from USFDA for its Nagpur facility

Earlier in May, in a regulatory filing Lupin had said that the US health regulator had completed inspection of the Nagpur facility without making any observations.

Sun Pharma shares gain 4% after USFDA clears drug major; market cap rises by Rs 2,384 cr

Shares of Sun Pharmaceutical Industries on Wednesday gained nearly 4 percent after the company received establishment inspection report (EIR) from the US health regulator for its Halol facility in Gujarat

Sun Pharma receives EIR for its crucial Halol plant in Gujarat, US health regulator clears drug major

Sun Pharmaceutical Industries said it has received establishment inspection report (EIR) from US health regulator for its Halol facility in Gujarat

Cadila Healthcare gets EIR for Ahmedabad plant from USFDA

The EIR report is given to an establishment after the completion of an inspection by the USFDA

Natco Pharma says USFDA clears inspection of its chemical division unit in Chennai

The USFDA released a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed